Medical Science Liaison-New York

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: New York City, NY | 06/01/2026 19:01:32 PM | Salario: S/. $195300 - 238700 per year | Empresa: Madrigal

Senior Clinical Supply Manager

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through...

Lugar: Conshohocken, PA | 06/01/2026 18:01:37 PM | Salario: S/. $152000 - 186000 per year | Empresa: Madrigal

Associate Director, Global Marketing

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase...

Lugar: Conshohocken, PA | 25/12/2025 03:12:42 AM | Salario: S/. $177000 - 216000 per year | Empresa: Madrigal

Director, R&D Strategic Sourcing and Procurement

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... will only pay a fee to agencies if a formal agreement between Madrigal and the agency has been established. Applications are being...

Lugar: Conshohocken, PA | 25/12/2025 01:12:38 AM | Salario: S/. $202000 - 246000 per year | Empresa: Madrigal

Senior Manager, Identity and Access Management

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: Pennsylvania | 20/12/2025 20:12:00 PM | Salario: S/. $160000 - 196000 per year | Empresa: Madrigal

Associate Director, Data and Analytics

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through...

Lugar: Waltham, MA | 13/12/2025 03:12:01 AM | Salario: S/. $171000 - 209000 per year | Empresa: Madrigal

Senior Manager, AI and Data Science

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial...

Lugar: Conshohocken, PA | 10/12/2025 00:12:09 AM | Salario: S/. $163000 - 200000 per year | Empresa: Madrigal

Senior Director, Commercial Patient Hub Data Operations

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: Conshohocken, PA | 06/12/2025 23:12:03 PM | Salario: S/. No Especificado | Empresa: Madrigal

Director, Data Architecture Development

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through...

Lugar: Waltham, MA | 06/12/2025 18:12:05 PM | Salario: S/. No Especificado | Empresa: Madrigal

Associate Director, Patient Support Solutions

treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can...

Lugar: Waltham, MA | 05/12/2025 02:12:28 AM | Salario: S/. $172000 - 210000 per year | Empresa: Madrigal
«Anterior12345